Kumar, Naveen
Bilinska, Adrianna
Menéndez, Elena
Stephan, Sarah
Rösch, Frank
Rominger, Axel
Gourni, Eleni https://orcid.org/0000-0003-2198-382X
Funding for this research was provided by:
University of Bern
Article History
Received: 26 May 2026
Accepted: 9 July 2026
First Online: 15 July 2026
Declarations
Ethics approval and consent to participate: All animal experiments were approved by local authorities and are in compliance with the institutional guidelines (Animal License Nr: BE87/2024).
Competing interests: Axel Rominger is an editor of the EJNMMI. Frank Rösch filed patents on FAPI-based radioligands. All other authors declare no competing interests.